Pfizer: Rectal Neoplasms trials
The registry lists 10 Rectal Neoplasms studies with Pfizer as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 1 4Phase 2 3Phase 3 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerActive, not recruitingNCT04607421Phase 3Results posted
- A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.TerminatedNCT06704724Phase 1
- A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.Active, not recruitingNCT06447662Phase 1
- A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid TumorsTerminatedNCT05983133Phase 1
- A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal CancerActive, not recruitingNCT05217446Phase 2
- A Study of ARRY-438162 (MEK162) in Patients With Advanced CancerCompletedNCT00959127Phase 1
- Study Evaluating EKB-569 in Advanced Colorectal CancerCompletedNCT00072748Phase 2
- Study Evaluating MAC-321 in Colorectal CancerCompletedNCT00063427Phase 2
- Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal CancerCompletedNCT00026273Phase 3
- Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal CancerCompletedNCT00004252Phase 3